Related Experiment Video
Updated: Oct 7, 2025

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential
Xiaojie Lin1, Yan Fang1, Xuechao Jin1
1Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning 117004, P. R. China.
Abstract:
There are always some components in the tumor microenvironment (TME), such as tumor-associated macrophages (TAMs), that help tumor cells escape the body's immune surveillance. Therefore, this situation can lead to tumor growth, progression, and metastasis, resulting in low response rates for cancer therapy. Macrophages play an important role with strong plasticity and functional diversity. Facing different microenvironmental stimulations, macrophages undergo a dynamic change in phenotype and function into two major macrophage subpopulations, namely classical activation/inflammation (M1) and alternative activation/regeneration (M2) type. Through various signaling pathways, macrophages polarize into complex groups, which can perform different immune functions. In this review, we emphasize the use of nanopreparations for macrophage related immunotherapy based on the pathological knowledge of TAMs phenotype. These macrophages targeted nanoparticles re-edit and re-educate macrophages by attenuating M2 macrophages and reducing aggregation to the TME, thereby relieving or alleviating immunosuppression. Among them, we describe in detail the cellular mechanisms and regulators of several major signaling pathways involved in the plasticity and polarization functions of macrophages. The advantages and challenges of those nanotherapeutics for these pathways have been elucidated, providing the basis and insights for the diagnosis and treatment strategies of various diseases centered on macrophages.
Insights
Nanoparticles can reprogram tumor-associated macrophages (TAMs) to enhance cancer immunotherapy. This approach targets M2 macrophages, reducing immunosuppression within the tumor microenvironment (TME) for better treatment outcomes.
Area of Science:
- Immunology
- Nanotechnology
- Oncology
Background:
- Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) promote immune evasion, leading to tumor growth and therapeutic resistance.
- Macrophages exhibit plasticity, differentiating into M1 (inflammatory) and M2 (regulatory) phenotypes, influencing immune responses.
- Understanding macrophage polarization is crucial for developing effective cancer immunotherapies.
Purpose of the Study:
- To review the application of nanopreparations in macrophage-centered immunotherapy.
- To explore how nanotherapeutics can modulate TAM phenotypes and functions within the TME.
- To provide insights into targeting macrophage plasticity for cancer treatment.
Main Methods:
- Review of literature on macrophage biology, TME components, and nanoparticle-based drug delivery.
- Analysis of signaling pathways regulating macrophage polarization (M1/M2).
- Evaluation of nanotherapeutics designed to attenuate M2 macrophages and reduce TME immunosuppression.
Main Results:
- Nanopreparations can be engineered to target and re-educate TAMs, shifting their phenotype from immunosuppressive M2 to anti-tumorigenic states.
- Targeted nanoparticles can reduce M2 macrophage aggregation in the TME, thereby alleviating immunosuppression.
- Detailed mechanisms of key signaling pathways governing macrophage plasticity and polarization are elucidated.
Conclusions:
- Macrophage-targeted nanopreparations offer a promising strategy for cancer immunotherapy by modulating the TME.
- Nanotherapeutics can overcome challenges associated with TAM-driven immunosuppression.
- This review provides a foundation for developing novel diagnostic and therapeutic strategies centered on macrophage manipulation in various diseases.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
The Tumor Microenvironment

